Inicio › Cáncer de ovario › Minnesota › Minneapolis
Ensayos clínicos de Cáncer de ovario en Minneapolis, MN
24 estudios para Cáncer de ovario buscan participantes en centros de Minneapolis y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
The Vanguard Study: Testing a New Way to Screen for Cancer
ReclutandoSe aceptan voluntarios sanos
- Minneapolis VA Medical Center, Minneapolis
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
ReclutandoFase 3
- Masonic Cancer Center, University of Minnesota, Minneapolis
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
ReclutandoFase 2
- Abbott-Northwestern Hospital, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · A 5 mi de distancia
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
ReclutandoFase 2
- Health Partners Frauenshuh Cancer Center, Saint Louis Park · A 5 mi de distancia
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
ReclutandoFase 2
- University Of Minnesota /ID# 277850, Minneapolis
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
ReclutandoFase 2
- University of Minnesota - Minneapolis /ID# 275718, Minneapolis
- Metro Minnesota Community Oncology Research Consortium (MMCORC) /ID# 274780, Saint Louis Park · A 5 mi de distancia
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
ReclutandoFase 2
- Minnesota Oncology-Minneapolis, Minneapolis
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
ReclutandoFase 1
- University of Minnesota Masonic Cancer Center, Minneapolis
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
ReclutandoFase 1
- University of Minnesota, Minneapolis
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
ReclutandoFase 1/2
- University of Minnesota/Masonic Cancer Center, Minneapolis
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
ReclutandoFase 1
- Normunity Investigational Site, Minneapolis
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Reclutando
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Health Partners Inc, Minneapolis
- y 2 más
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
ReclutandoFase 3
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Health Partners Inc, Minneapolis
- y 2 más
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
ReclutandoFase 1/2
- M Health Fairview University of Minnesota Medical Center, Minneapolis
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
ReclutandoFase 2
- 518, Minneapolis
Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer
ReclutandoFase 2
- University of Minnesota - Masonic Cancer Center, Minneapolis
UNTOLD Ovarian Cancer Unmet Needs Survey
ReclutandoEstudio observacional
- Masonic Cancer Center, Minneapolis
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
ReclutandoFase 1
- Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
ReclutandoFase 3
- Minnesota Oncology Hematology PA, Minneapolis
Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women
ReclutandoSe aceptan voluntarios sanos
- University of Minnesota, Minneapolis
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
ReclutandoFase 1
- University of Minnesota, Minneapolis
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Allina Health Cancer Institute, Minneapolis
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
ReclutandoFase 2
- SCRI - Minnesota Oncology Hematology, P.A., Minneapolis
- University of Minnesota, Minneapolis
A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian Cancer
ReclutandoFase 1
- University of Minnesota, Minneapolis
Más información sobre Cáncer de ovario en MedlinePlus
Ensayos de Cáncer de ovario en otras ciudades
- Houston, TX89 estudios
- New York City, NY69 estudios
- Boston, MA61 estudios
- Los Angeles, CA50 estudios
- Nashville, TN49 estudios
- Arlington, VA46 estudios
- Philadelphia, PA44 estudios
- Columbus, OH39 estudios
- St. Louis, MO38 estudios
- Chicago, IL36 estudios
- San Antonio, TX31 estudios
- Cleveland, OH30 estudios
Otros estudios en Minneapolis
- Cáncer de pulmón de células no pequeñas27 estudios
- Cáncer de seno27 estudios
- Cáncer de próstata23 estudios
- Cáncer (todos los tipos)22 estudios
- Fallo cardíaco21 estudios
- Leucemia mielógena aguda20 estudios
- Cáncer de pulmón20 estudios
- Cáncer del colon y del recto19 estudios
- Cáncer de endometrio18 estudios
- Enfermedad de Parkinson17 estudios
- Enfermedad cardiovascular15 estudios
- Enfermedad de las arterias coronarias13 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.